{"id":267713,"date":"2024-09-10T23:31:00","date_gmt":"2024-09-09T18:04:00","guid":{"rendered":"https:\/\/hispanicprwire.com\/english-highmark-first-to-cover-appliedvrs-flagship-vr-device-for-chronic-low-back-pain-treatment\/"},"modified":"2024-09-10T23:40:01","modified_gmt":"2024-09-11T03:40:01","slug":"highmark-es-el-primero-en-dar-cobertura-al-dispositivo-de-realidad-virtual-insignia-de-appliedvr-para-el-tratamiento-del-dolor-lumbar-cronico","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/highmark-es-el-primero-en-dar-cobertura-al-dispositivo-de-realidad-virtual-insignia-de-appliedvr-para-el-tratamiento-del-dolor-lumbar-cronico\/","title":{"rendered":"Highmark First to Cover AppliedVR&#8217;s Flagship VR Device for Chronic Low Back Pain Treatment"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p class=\"prntac\"><i>FDA-authorized RelieVRx now a covered treatment for Highmark&#8217;s commercial members experiencing chronic low back pain (CLBP)<\/i><\/p>\n<p><span class=\"xn-location\">PITTSBURGH<\/span>, <span class=\"xn-chron\">Sept. 9, 2024<\/span> \/PRNewswire-HISPANIC PR WIRE\/&#8211;\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1857097477&amp;u=https%3A%2F%2Fappliedvr.io%2F&amp;a=AppliedVR\" target=\"_blank\" rel=\"nofollow\">AppliedVR<\/a><\/u>, a pioneer in immersive therapeutics (ITx) advancing virtual reality-based medicine, announced today that Highmark, a leading commercial health insurance plan based in <span class=\"xn-location\">Pittsburgh, PA<\/span>, will now cover <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=251750196&amp;u=https%3A%2F%2Fwww.relievrx.com%2F&amp;a=RelieVRx\" target=\"_blank\" rel=\"nofollow\">RelieVRx<\/a><\/u>, AppliedVR&#8217;s FDA-authorized device for chronic low back pain (CLBP). This landmark decision makes RelieVRx accessible as a covered therapeutic to more than four million Highmark members across its commercial lines of business.<\/p>\n<div id=\"prni_dvprnejpgb386left\" dir=\"ltr\" style=\"width: 100%; text-align: left;\"><img decoding=\"async\" id=\"prnejpgb386left\" title=\"RelieVRx program is covered by Highmark.\" src=\"https:\/\/mma.prnewswire.com\/media\/2498127\/Highmark_AVR.jpg\" alt=\"RelieVRx program is covered by Highmark.\" align=\"middle\"\/><\/div>\n<p>RelieVRx offers a fully immersive virtual reality (VR) experience designed to empower individuals with skills for managing CLBP. It serves as a cost-effective, non-pharmacologic adjunctive therapy clinically proven to significantly reduce pain intensity and interference <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=3913531154&amp;u=https%3A%2F%2Fwww.liebertpub.com%2Fdoi%2F10.1089%2Fjmxr.2023.0013&amp;a=across+sociodemographic+groups\" target=\"_blank\" rel=\"nofollow\">across sociodemographic groups<\/a><\/u>.<\/p>\n<p>Patients using RelieVRx undergo a 56-session, multimodal program, featuring daily VR sessions that address the bio-psycho-social aspects of pain. RelieVRx is self-administered by patients in their own homes and has an easy-to-use interface. In clinical testing, RelieVRx usability ratings were consistently high (A+), which was largely consistent across subgroups.<sup><sup>1<\/sup><\/sup><\/p>\n<p>Highmark&#8217;s decision to cover RelieVRx follows a thorough evaluation of AppliedVR&#8217;s extensive clinical studies, including a <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1810892053&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fappliedvr-releases-outcomes-data-from-the-largest-clinical-trial-to-study-home-based-virtual-reality-treatment-of-chronic-low-back-pain-301978183.html&amp;a=large+study\" target=\"_blank\" rel=\"nofollow\">large study<\/a><\/u> with more than 1,000 participants that found RelieVRx can have a clinically meaningful impact on reducing pain intensity and interference. Eligible commercial members aged 18 and older diagnosed with moderate to severe CLBP can now obtain a prescription for RelieVRx from their healthcare provider without prior authorization.<\/p>\n<p>&#8220;We are committed to leveraging technology to enhance health outcomes while reducing costs,&#8221; said <span class=\"xn-person\">Matt Fickie<\/span>, Senior Medical Director for Highmark. &#8220;RelieVRx from AppliedVR provides our members suffering from chronic low back pain a scientifically backed, in-home immersive non-opioid treatment option.&#8221;<\/p>\n<p>Chronic pain imposes a significant economic burden on the U.S., estimated at <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=551252601&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4016362-1%26h%3D1596917879%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3811249-1%2526h%253D2668864462%2526u%253Dhttps%25253A%25252F%25252Fcts.businesswire.com%25252Fct%25252FCT%25253Fid%25253Dsmartlink%252526url%25253Dhttps%2525253A%2525252F%2525252Fwww.sciencedaily.com%2525252Freleases%2525252F2012%2525252F09%2525252F120911091100.htm%252526esheet%25253D52700176%252526newsitemid%25253D20220428005360%252526lan%25253Den-US%252526anchor%25253Destimated%252526index%25253D4%252526md5%25253Deaa8d52cf057ce43b446520f64c56d70%252526_gl%25253D1*60zcz5*_ga*ODU1NDM0MTA5LjE2NTkzMDUzODQ.*_ga_ZQWF70T3FK*MTY3ODQ4MjYyOS4xMTguMC4xNjc4NDgyNjI5LjYwLjAuMA..%2526a%253Destimated%252B%252524635%252Bbillion%26a%3Dcosts&amp;a=%24635+billion+annually\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-money\">$635 billion<\/span> annually<\/a><\/u>, and is a primary driver of the opioid crisis. More than <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1856976681&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4016362-1%26h%3D137001188%26u%3Dhttps%253A%252F%252Fknowyourbackstory.com%252Fmanage%252Fwp-content%252Fuploads%252F2022%252F08%252FHARRIS-POLL-EXECUTIVE-SUMMARY-RESULTS.pdf%26a%3DResearch&amp;a=72+million+Americans\" target=\"_blank\" rel=\"nofollow\">72 million Americans<\/a><\/u> suffer from CLBP, which also is a <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=2104319134&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4016362-1%26h%3D1460761855%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3811249-1%2526h%253D347659811%2526u%253Dhttps%25253A%25252F%25252Fwww.iasp-pain.org%25252Fresources%25252Ffact-sheets%25252Fthe-global-burden-of-low-back-pain%25252F%252523%25253A%25257E%25253Atext%25253DLow%25252520back%25252520pain%25252520is%25252520the%25252520leading%25252520cause%25252520of%25252520global%25252520disability.%252526text%25253DApproximately%2525252070%25252525%25252520of%25252520years%25252520lost%25252C65%25252520years)%25252520%2525255B5%2525255D.%2526a%253Dleading%252Bcause%252Bof%252Bdisability%26a%3Dleading%2Bcause%2Bof%2Bdisability&amp;a=leading+cause\" target=\"_blank\" rel=\"nofollow\">leading cause<\/a><\/u> of disability.<\/p>\n<p>&#8220;Every individual battling CLBP deserves access to noninvasive, drug-free options that empower them to self-manage their pain. Highmark&#8217;s forward-thinking approach recognizes the promise of immersive therapeutics, and we are grateful for their collaboration,&#8221; said <span class=\"xn-person\">Matthew Stoudt<\/span>, Co-founder and CEO of AppliedVR. &#8220;RelieVRx is based on decades of clinical evidence demonstrating the transformative potential of immersive therapeutics to reshape the body&#8217;s response to pain, and we are committed to building an even greater body of evidence that continues to set the industry standard.&#8221;<\/p>\n<p>While Highmark becomes the first commercial health plan to adopt coverage for RelieVRx, AppliedVR has experienced significant momentum with payers over the last year:<\/p>\n<ul type=\"disc\">\n<li>RelieVRx previously received <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1116954043&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fappliedvr-becomes-first-virtual-reality-provider-to-receive-hcpcs-level-ii-code-from-centers-for-medicare-and-medicaid-services-as-durable-medical-equipment-301773521.html&amp;a=a+\" target=\"_blank\" rel=\"nofollow\">a <\/a><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1779242059&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fappliedvr-becomes-first-virtual-reality-provider-to-receive-hcpcs-level-ii-code-from-centers-for-medicare-and-medicaid-services-as-durable-medical-equipment-301773521.html&amp;a=unique+code\" target=\"_blank\" rel=\"nofollow\">unique code<\/a><\/u> and final pricing determination from the Centers for Medicare and Medicaid Services (CMS).<\/li>\n<li>RelieVRx <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=264240069&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fappliedvr-partners-with-lovell-to-better-serve-government-healthcare-systems-301792699.html&amp;a=was+added\" target=\"_blank\" rel=\"nofollow\">was added<\/a><\/u> to the Department of Veterans Affairs&#8217; Federal Supply Schedule (FSS), Defense Logistics Agency&#8217;s Electronic Catalogue for Medical Supply Chain (ECAT), and the Department of Defense&#8217;s Distribution and Pricing Agreement (DAPA), allowing government customers to make streamlined purchases. RelieVRx is now available nationwide and is currently used in more than 40 Veterans Affairs (VA) sites.<\/li>\n<li>VA Immersive, a division of Veterans Health Administration (VHA), <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1361752585&amp;u=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fveterans-health-administration-extends-contract-with-appliedvr-to-continue-use-of-virtual-reality-for-treating-chronic-low-back-pain-302019719.html&amp;a=extended+its+contract\" target=\"_blank\" rel=\"nofollow\">extended its contract<\/a><\/u> with AppliedVR to facilitate accelerated uptake.<\/li>\n<li>AppliedVR also recently expanded into the <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=2907600236&amp;u=https%3A%2F%2Fwww.appliedvr.io%2Fworkerscomp&amp;a=Worker%27s+Compensation+market\" target=\"_blank\" rel=\"nofollow\">Worker&#8217;s Compensation market<\/a><\/u>.<\/li>\n<\/ul>\n<p><b>About AppliedVR<br \/><\/b>AppliedVR is creating a new reality in healthcare. AVR is pioneering immersive therapeutics (ITx), a new category of medicine, to treat intractable health conditions that affect millions of people worldwide. Today, AppliedVR&#8217;s treatments represent a robust approach to chronic lower back pain (CLBP) that empowers patients with an intuitive device they can self-manage at home. For more information, visit <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=3098513007&amp;u=http%3A%2F%2Fwww.appliedvr.io%2F&amp;a=www.appliedvr.io\" target=\"_blank\" rel=\"nofollow\">www.appliedvr.io<\/a><\/u>.<\/p>\n<p><sup><sup>1<\/sup><\/sup>\u00a0Research indicated some slight differences among race\/ethnicity.<\/p>\n<p>Contacts<br \/><span class=\"xn-person\">Sam Moore<\/span><br \/><u><a href=\"mailto:press@appliedvr.io\" target=\"_blank\" rel=\"nofollow\">press@appliedvr.io<\/a><\/u><\/p>\n<div id=\"prni_dvprnejpgb8afleft\" dir=\"ltr\" style=\"width: 100%; text-align: left;\"><img decoding=\"async\" id=\"prnejpgb8afleft\" title=\" \" src=\"https:\/\/mma.prnewswire.com\/media\/1685727\/AppliedVR_Logov1.jpg\" alt=\" \" align=\"middle\"\/><\/div>\n<p>Photo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=131225537&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2498127%2FHighmark_AVR.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F2498127%2FHighmark_AVR.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/2498127\/Highmark_AVR.jpg<\/a><br \/>Logo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=3759113149&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1685727%2FAppliedVR_Logov1.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1685727%2FAppliedVR_Logov1.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/1685727\/AppliedVR_Logov1.jpg<\/a><\/p>\n<p>SOURCE  AppliedVR<\/p>\n<\/div>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p class=\"prntac\"><i>FDA-authorized RelieVRx now a covered treatment for Highmark&#8217;s commercial members experiencing chronic low back pain (CLBP)<\/i><\/p>\n<p><span class=\"xn-location\">PITTSBURGH<\/span>, <span class=\"xn-chron\">Sept. 9, 2024<\/span> \/PRNewswire-HISPANIC PR WIRE\/&#8211;\u00a0<u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4248226-1&amp;h=1857097477&amp;u=https%3A%2F%2Fappliedvr.io%2F&amp;a=AppliedVR\" target=\"_blank\" rel=\"nofollow noopener\">AppliedVR<\/a><\/u>, a pioneer in immersive therapeutics (ITx) advancing virtual reality-based medicine, announced today that&#8230;<\/p>\n","protected":false},"author":1,"featured_media":267714,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-267713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/267713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=267713"}],"version-history":[{"count":"1","href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/267713\/revisions"}],"predecessor-version":[{"id":267749,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/267713\/revisions\/267749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media\/267714"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=267713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=267713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=267713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}